News 
Market Data 
Discover
tjguy
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
| Ticker | Board | News | Price | Change | Chg% | Added | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| CWBR | CohBar Inc | 0 | 0 | 0.00% | 01/09/2021 | |||||
|
My CWBR Pitch: Stock with great potential that has fallen out of favor, but expect a resumption of their FDA trial soon. They continue to develop more molecules for future applications. Seems like they are coming out of their funk.
|
||||||||||
| DPRO | Draganfly Inc | 0.2402 | 0.0273 | 12.82% | 01/09/2021 | |||||
|
My DPRO Pitch: Drone company that has recently locked down a number of government contracts and has a covid-19 element to it as well. Contracted by one US college to protect their sports facilities by flying their drones to sterilize their facilities. Great growth potential and upward price movement.
|
||||||||||
| RECAF | Reconnaissance Energy Africa Ltd | 0.82 | -0.05 | -5.75% | 01/09/2021 | |||||
|
My RECAF Pitch: Conventional oil play in Namibia/Botswana on undrilled land. Drilling first wells now. Profitable at $35 oil & currently oil is over $50!! Risk is a tad high until reserves proven. Experts see potential for billions of barrels here. Stay tuned in 1H 2021!
|
||||||||||
| MDNAF | Medicenna Therapeutics Corp | 1.99 | 0.21 | 11.80% | 01/09/2021 | |||||
|
My MDNAF Pitch: Great results in their MDNA 55 trial for glioblastoma - brain cancer. Should partner for Phase 3 in spring or summer of '21. Then they will bring their IL-2 drug into the clinic and it has tremendous potential and pre-clinical indications are VERY positive. 2021 will be a huge year for them!
|
||||||||||
| DMAC | DiaMedica Therapeutics Inc | 3.665 | 0.165 | 4.71% | 01/09/2021 | |||||
|
My DMAC Pitch: Their current drug will read out Phase 2 data in spring of '21. IF positive, - and all indications are that it should be - it should be a huge inflection point. Great potential. Low risk because this drug simply mimics a natural substance - tissue kallikrein - that is already known to work.
|
||||||||||
| KNW | Know Labs Inc | 0.65715 | 0.03715 | 5.99% | 01/09/2021 | |||||
|
My KNW Pitch: Unbelievable potential here for the non-invasive blood glucose monitoring technology IF it proves out. We are still in the validation stage so quiet risky here. But back up the truck and buy once it is validated! If you have a high risk tolerance, then might want to pick some up even at this level.
|
||||||||||
